EP1810026
B7-H1 og PD-1 í meðhöndlun á nýrnafrumukrabbameini
Status:
EP Einkaleyfi ógilt eftir andmæliEP appl. date:
6.10.2005EP published:
18.4.2018EP application number:
05808659.6
EP translation filed:
11.6.2018Grant published:
15.7.2018EPO information:
European Patent Register
Max expiry date:
5.10.2025Expiry date:
5.10.2024
Title:
B7-H1 AND PD-1 IN TREATMENT OF RENAL CELL CARCINOMA
Timeline
Today
6.10.2005EP application
18.4.2018EP Publication
11.6.2018Translation submitted
15.7.2018Registration published
5.10.2024Expires
Owner
Name:
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCHAddress:
200 First Street S.W., 55905, Rochester, MN, US
Inventor
Name:
CHENG, LiepingAddress:
Sparks Glencoe, MD, US
Name:
STROME, Scott, E.Address:
Reisterstown, MD, US
Name:
KWON, Eugene, D.Address:
Rochester, MN, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
616590 PDate:
6.10.2004Country:
US
Number:
642794 PDate:
11.1.2005Country:
US
Classification
Categories:
A61K 39/395, G01N 33/574
Annual fees
Number
Paid
Expires
Payer
Number: 14
Paid: 18.9.2018
Expires: 5.10.2019
Payer: Sigurjónsson & Thor ehf.
Number: 15
Paid: 18.9.2019
Expires: 5.10.2020
Payer: Sigurjónsson & Thor ehf.
Number: 16
Paid: 18.9.2020
Expires: 5.10.2021
Payer: Sigurjónsson & Thor ehf.
Number: 17
Paid: 20.9.2021
Expires: 5.10.2022
Payer: Sigurjónsson & Thor ehf.
Number: 18
Paid: 3.10.2022
Expires: 5.10.2023
Payer: Patice ehf.
Number: 19
Paid: 11.10.2023
Expires: 5.10.2024
Payer: Árnason Faktor ehf.